BDNF
14
2
4
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
7.1%
1 terminated out of 14 trials
88.9%
+2.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (14)
Comparing Touch-Limited and Free-Play 4v4 Small-Sided Games (SSGs)
Daily Fluctuations in Brain-Derived Neurotrophic Factor and Cognition: Effects of Vigorous Exercise
Acute Neurochemical and Cognitive Changes After HIIT vs MICT/LICT
Effects of Different Types of Exercise on BDNF and Cognitive Performance (Exercise-BDNF)
Home-based Transcranial Direct Current Stimulation (tDCS) Compared to Duloxetine: Non-inferiority Clinical Trial (FIBROSTIM)
Impact of Nut Consumption on Mental Health in Young Adults
The Acute Effect of Different Resistance Exercise Loads on Irisin and Brain-derived Neurotrophic Factor in Blood Serum and Plasma
Investigating the Evolutionary Impact of Metabolic Flexibility on Physical Activity-Dependent BDNF and Cognition: Insights From the Val66Met Polymorphism
Determination of BDNF Peak Time in Different Types of Exercises
BDNF Levels in Cancer Patients Receiving Chemotherapy
The Relationship Between Delirium and BDNF in Coronary Artery Bypass Graft Surgery
BDNF Promoter Methylation: Effects on Cognition, Stress and Anxiety and Depression Symptom in Healthy Women.
Serum BDNF Role as a Biomarker for Stroke Rehabilitation
BDNF and Motor Learning